Beam Therapeutics BEAM Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Plus components not separately reported this period.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's total debt?
- Beam Therapeutics (BEAM) reported total debt of $250.82M in Q1 2026.
- How has Beam Therapeutics's total debt changed year-over-year?
- Beam Therapeutics's total debt increased by 58.6% year-over-year, from $158.13M to $250.82M.
- What is the long-term trend for Beam Therapeutics's total debt?
- Over 5 years (2020 to 2025), Beam Therapeutics's total debt has grown at a 7.4% compound annual growth rate (CAGR), from $107.64M to $154.12M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.